
James William Rogers
Examiner (ID: 13796)
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1194 |
| Issued Applications | 502 |
| Pending Applications | 144 |
| Abandoned Applications | 586 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20307849
[patent_doc_number] => 20250325478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-23
[patent_title] => STABLE INTRAVENOUS DILTIAZEM HYDROCHLORIDE FORMULATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/249149
[patent_app_country] => US
[patent_app_date] => 2025-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19249149
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/249149 | STABLE INTRAVENOUS DILTIAZEM HYDROCHLORIDE FORMULATION AND USE THEREOF | Jun 24, 2025 | Pending |
Array
(
[id] => 20307848
[patent_doc_number] => 20250325477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-23
[patent_title] => STABLE INTRAVENOUS DILTIAZEM HYDROCHLORIDE FORMULATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/249060
[patent_app_country] => US
[patent_app_date] => 2025-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19249060
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/249060 | STABLE INTRAVENOUS DILTIAZEM HYDROCHLORIDE FORMULATION AND USE THEREOF | Jun 24, 2025 | Pending |
Array
(
[id] => 20348478
[patent_doc_number] => 20250345330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-13
[patent_title] => COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL
[patent_app_type] => utility
[patent_app_number] => 19/218211
[patent_app_country] => US
[patent_app_date] => 2025-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19218211
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/218211 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | May 22, 2025 | Pending |
Array
(
[id] => 20348478
[patent_doc_number] => 20250345330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-13
[patent_title] => COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL
[patent_app_type] => utility
[patent_app_number] => 19/218211
[patent_app_country] => US
[patent_app_date] => 2025-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19218211
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/218211 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | May 22, 2025 | Pending |
Array
(
[id] => 19808382
[patent_doc_number] => 12239741
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-03-04
[patent_title] => Hydroxyapatite-enclosed zinc phosphate nanocomposite
[patent_app_type] => utility
[patent_app_number] => 18/915867
[patent_app_country] => US
[patent_app_date] => 2024-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 42
[patent_no_of_words] => 11034
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18915867
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/915867 | Hydroxyapatite-enclosed zinc phosphate nanocomposite | Oct 14, 2024 | Issued |
Array
(
[id] => 19875756
[patent_doc_number] => 20250108013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => POLYMER NANOPARTICLE COMPOSITIONS FOR IN VIVO EXPRESSION OF POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 18/902113
[patent_app_country] => US
[patent_app_date] => 2024-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18902113
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/902113 | Polymer nanoparticle compositions for in vivo expression of polypeptides | Sep 29, 2024 | Issued |
Array
(
[id] => 19752896
[patent_doc_number] => 20250041461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/791288
[patent_app_country] => US
[patent_app_date] => 2024-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 94088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18791288
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/791288 | [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF | Jul 30, 2024 | Pending |
Array
(
[id] => 20163928
[patent_doc_number] => 20250255974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-14
[patent_title] => COMPLEX
[patent_app_type] => utility
[patent_app_number] => 19/108248
[patent_app_country] => US
[patent_app_date] => 2024-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19108248
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/108248 | COMPLEX | May 30, 2024 | Pending |
Array
(
[id] => 20163928
[patent_doc_number] => 20250255974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-14
[patent_title] => COMPLEX
[patent_app_type] => utility
[patent_app_number] => 19/108248
[patent_app_country] => US
[patent_app_date] => 2024-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19108248
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/108248 | COMPLEX | May 30, 2024 | Pending |
Array
(
[id] => 19510600
[patent_doc_number] => 20240342286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => NEAR-INFRARED (NIR) ABSORBING PHOTOSENSITIZERS
[patent_app_type] => utility
[patent_app_number] => 18/669670
[patent_app_country] => US
[patent_app_date] => 2024-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 1016
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18669670
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/669670 | NEAR-INFRARED (NIR) ABSORBING PHOTOSENSITIZERS | May 20, 2024 | Pending |
Array
(
[id] => 19402283
[patent_doc_number] => 20240285794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => HYDROGELS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/643966
[patent_app_country] => US
[patent_app_date] => 2024-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18643966
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/643966 | HYDROGELS AND METHODS OF USING THE SAME | Apr 22, 2024 | Pending |
Array
(
[id] => 19593209
[patent_doc_number] => 12151027
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-11-26
[patent_title] => Chitosan-hybridized zinc phosphate/hydroxyapatite nanostructure-based drug delivery system
[patent_app_type] => utility
[patent_app_number] => 18/640787
[patent_app_country] => US
[patent_app_date] => 2024-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 42
[patent_no_of_words] => 11070
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18640787
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/640787 | Chitosan-hybridized zinc phosphate/hydroxyapatite nanostructure-based drug delivery system | Apr 18, 2024 | Issued |
Array
(
[id] => 19359195
[patent_doc_number] => 20240261229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => NANOPARTICLES WITH NON-COVALENTLY BOUND TARGETING MOIETIES FOR USE IN A THERAPEUTIC METHOD AND FOR NON-MEDICAL USE
[patent_app_type] => utility
[patent_app_number] => 18/637431
[patent_app_country] => US
[patent_app_date] => 2024-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 431
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18637431
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/637431 | NANOPARTICLES WITH NON-COVALENTLY BOUND TARGETING MOIETIES FOR USE IN A THERAPEUTIC METHOD AND FOR NON-MEDICAL USE | Apr 15, 2024 | Abandoned |
Array
(
[id] => 19359195
[patent_doc_number] => 20240261229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => NANOPARTICLES WITH NON-COVALENTLY BOUND TARGETING MOIETIES FOR USE IN A THERAPEUTIC METHOD AND FOR NON-MEDICAL USE
[patent_app_type] => utility
[patent_app_number] => 18/637431
[patent_app_country] => US
[patent_app_date] => 2024-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 431
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18637431
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/637431 | NANOPARTICLES WITH NON-COVALENTLY BOUND TARGETING MOIETIES FOR USE IN A THERAPEUTIC METHOD AND FOR NON-MEDICAL USE | Apr 15, 2024 | Abandoned |
Array
(
[id] => 19543036
[patent_doc_number] => 20240360072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => Cationic Lipid Compound and Composition for Delivery of Nucleic Acids and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 18/625544
[patent_app_country] => US
[patent_app_date] => 2024-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18625544
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/625544 | Cationic lipid compound and composition for delivery of nucleic acids and use thereof | Apr 2, 2024 | Issued |
Array
(
[id] => 19930380
[patent_doc_number] => 12303573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-20
[patent_title] => Formulation of contrast media and process of preparation thereof
[patent_app_type] => utility
[patent_app_number] => 18/617245
[patent_app_country] => US
[patent_app_date] => 2024-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12676
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18617245
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/617245 | Formulation of contrast media and process of preparation thereof | Mar 25, 2024 | Issued |
Array
(
[id] => 19246980
[patent_doc_number] => 20240197964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => GEL MATERIAL FOR OPHTHALMIC TREATMENT USE
[patent_app_type] => utility
[patent_app_number] => 18/595720
[patent_app_country] => US
[patent_app_date] => 2024-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 305
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18595720
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/595720 | GEL MATERIAL FOR OPHTHALMIC TREATMENT USE | Mar 4, 2024 | Abandoned |
Array
(
[id] => 19526627
[patent_doc_number] => 20240350529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/588605
[patent_app_country] => US
[patent_app_date] => 2024-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18588605
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/588605 | COMPOSITIONS AND METHODS OF USE THEREOF | Feb 26, 2024 | Pending |
Array
(
[id] => 19519892
[patent_doc_number] => 12121591
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-22
[patent_title] => Sulfur-containing ionizable lipids for the delivery of nucleic acids and other therapeutic agents
[patent_app_type] => utility
[patent_app_number] => 18/392458
[patent_app_country] => US
[patent_app_date] => 2023-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 24391
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 264
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18392458
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/392458 | Sulfur-containing ionizable lipids for the delivery of nucleic acids and other therapeutic agents | Dec 20, 2023 | Issued |
Array
(
[id] => 19156173
[patent_doc_number] => 20240148880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => REJUVENATION OF CAR T CELL
[patent_app_type] => utility
[patent_app_number] => 18/392939
[patent_app_country] => US
[patent_app_date] => 2023-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8898
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18392939
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/392939 | REJUVENATION OF CAR T CELL | Dec 20, 2023 | Pending |